SAMPANNRubber
Sampann Utpadan India Limited — Profit & Loss Statement
₹24.33
-2.37%
Sampann Utpadan India Limited Profit & Loss Statement (Annual)
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Tax Effect Of Unusual Items | 2.11 Cr | 0.00 | 95802.33 | -0.02 Cr | — |
| Tax Rate For Calcs | 0.26 | 0.02 | 0.25 | 0.25 | — |
| Normalized EBITDA | 3.99 Cr | 5.14 Cr | 3.52 Cr | 3.92 Cr | — |
| Total Unusual Items | 8.11 Cr | 0.00 | 0.04 Cr | -0.10 Cr | — |
| Total Unusual Items Excluding Goodwill | 8.11 Cr | 0.00 | 0.04 Cr | -0.10 Cr | — |
| Net Income From Continuing Operation Net Minority Interest | 3.98 Cr | -0.87 Cr | -1.69 Cr | -2.97 Cr | — |
| Reconciled Depreciation | 5.71 Cr | 5.02 Cr | 4.83 Cr | 4.46 Cr | — |
| Reconciled Cost Of Revenue | 82.15 Cr | 57.47 Cr | 47.54 Cr | 38.44 Cr | — |
| EBITDA | 12.10 Cr | 5.14 Cr | 3.56 Cr | 3.82 Cr | — |
| EBIT | 6.39 Cr | 0.12 Cr | -1.27 Cr | -0.64 Cr | — |
| Net Interest Income | -1.01 Cr | -1.00 Cr | -1.02 Cr | -3.36 Cr | — |
| Interest Expense | 1.01 Cr | 1.00 Cr | 0.98 Cr | 3.32 Cr | — |
| Normalized Income | -2.02 Cr | -0.87 Cr | -1.71 Cr | -2.90 Cr | — |
| Net Income From Continuing And Discontinued Operation | 3.98 Cr | -0.87 Cr | -1.69 Cr | -2.97 Cr | — |
| Total Expenses | 99.55 Cr | 71.70 Cr | 59.43 Cr | 49.10 Cr | — |
| Diluted Average Shares | 4.06 Cr | 4.13 Cr | 4.06 Cr | 4.06 Cr | — |
| Basic Average Shares | 4.06 Cr | 4.13 Cr | 4.06 Cr | 4.06 Cr | — |
| Diluted EPS | 0.98 | -0.21 | -0.41 | -0.73 | — |
| Basic EPS | 0.98 | -0.21 | -0.41 | -0.73 | — |
| Diluted NI Availto Com Stockholders | 3.98 Cr | -0.87 Cr | -1.69 Cr | -2.97 Cr | — |
| Net Income Common Stockholders | 3.98 Cr | -0.87 Cr | -1.69 Cr | -2.97 Cr | — |
| Otherunder Preferred Stock Dividend | 0.00 | 0.00 | 0.00 | 0.00 | — |
| Net Income | 3.98 Cr | -0.87 Cr | -1.69 Cr | -2.97 Cr | — |
| Net Income Including Noncontrolling Interests | 3.98 Cr | -0.87 Cr | -1.69 Cr | -2.97 Cr | — |
| Net Income Continuous Operations | 3.98 Cr | -0.87 Cr | -1.69 Cr | -2.97 Cr | — |
| Tax Provision | 1.40 Cr | -0.02 Cr | -0.56 Cr | -0.99 Cr | — |
| Pretax Income | 5.38 Cr | -0.88 Cr | -2.24 Cr | -3.96 Cr | — |
| Other Non Operating Income Expenses | 5.19 Cr | 0.37 Cr | 0.35 Cr | 0.48 Cr | — |
| Special Income Charges | 8.11 Cr | 0.00 | 0.04 Cr | -0.10 Cr | — |
| Other Special Charges | -8.11 Cr | -28314.00 | — | -0.13 Cr | 0.56 Cr |
| Net Non Operating Interest Income Expense | -1.01 Cr | -1.00 Cr | -1.02 Cr | -3.36 Cr | — |
| Interest Expense Non Operating | 1.01 Cr | 1.00 Cr | 0.98 Cr | 3.32 Cr | — |
| Operating Income | -6.91 Cr | -0.25 Cr | -1.69 Cr | -1.06 Cr | — |
| Operating Expense | 17.40 Cr | 14.23 Cr | 11.89 Cr | 10.66 Cr | — |
| Other Operating Expenses | 8.03 Cr | 6.65 Cr | 0.66 Cr | 0.73 Cr | — |
| Depreciation And Amortization In Income Statement | 5.71 Cr | 5.02 Cr | 4.83 Cr | 4.46 Cr | — |
| Depreciation Income Statement | 5.71 Cr | 5.02 Cr | 4.83 Cr | 4.46 Cr | — |
| Gross Profit | 10.49 Cr | 13.98 Cr | 10.20 Cr | 9.59 Cr | — |
| Cost Of Revenue | 82.15 Cr | 57.47 Cr | 47.54 Cr | 38.44 Cr | — |
| Total Revenue | 92.64 Cr | 71.45 Cr | 57.74 Cr | 48.04 Cr | — |
| Operating Revenue | 92.64 Cr | 71.45 Cr | 57.74 Cr | 48.04 Cr | — |
| Interest Income | — | 0.06 Cr | 0.08 Cr | 0.08 Cr | 0.08 Cr |
| Rent Expense Supplemental | — | 0.22 Cr | 0.12 Cr | 0.14 Cr | 0.16 Cr |
| Write Off | — | 20282.00 | -0.04 Cr | 0.23 Cr | 0.23 Cr |
| Total Other Finance Cost | — | 0.12 Cr | 0.13 Cr | 0.12 Cr | 0.03 Cr |
| Interest Income Non Operating | — | 0.06 Cr | 0.08 Cr | 0.08 Cr | 0.08 Cr |
| Selling General And Administration | — | 5.10 Cr | 3.98 Cr | 3.38 Cr | 1.75 Cr |
| Selling And Marketing Expense | — | 4.47 Cr | 3.46 Cr | 2.89 Cr | 1.35 Cr |
| General And Administrative Expense | — | 0.63 Cr | 0.52 Cr | 0.49 Cr | 0.39 Cr |
| Rent And Landing Fees | — | 0.22 Cr | 0.12 Cr | 0.14 Cr | 0.16 Cr |
All figures in ₹ Crores. Source: NSE/BSE filings via Bull Run.
More on Sampann Utpadan India Limited
Data from NSE/BSE public filings. Educational purposes only. Bull Run is not SEBI-registered. Not investment advice.